Bodycad Gains Regulatory Approval in Canada for BC Fine Osteotomy
BC Fine Osteotomy offers a procedural solution adapted to each patient and is delivered as a procedure in a box to drive efficiency in the O.R. May 20, 2020
Cerapedics Announces Results from Clinical Trial of i-FACTOR in Lumbar Fusion
Results show that elderly patients undergoing non-instrumented fusion achieve statistically significantly higher fusion rates with i-FACTOR vs. allograft. May 19, 2020
NG Medical Launches BEE 3D Ti Cervical Interbody Cage
The BEE 3D Ti cage features a honeycomb structure designed to optimize bone ingrowth and fusion while reducing subsidence. May 18, 2020
Implanet to Divest Madison Total Knee Assets, Focus on Spine
The exclusive negotiations to sell the Madison total knee implant allow the company to focus on growing its spine business. May 18, 2020
Zebra Medical Vision Gains FDA Clearance for Spine Fracture AI Solution
Zebra-Med secured clearance for a product helping to identify more patients at risk of osteoporosis, as 70% of VCFs are underdetected globally. May 18, 2020
Bone Therapeutics Treats First Patients in Phase III Knee Osteoarthritis Study
The JTA-004 Phase III study is approved in five of seven territories. These are the first patients treated after resumption of clinical activities. May 18, 2020
Neo Medical Raises Funding for Growth in Spinal Fusion
Neo Medical has developed a universal surgical platform, including five instruments and fourteen implants covering most spine indications. May 15, 2020
Foresee-X Smart Surgical Glasses Gain CE Mark Approval
The system allows for reduction in the use of external monitors during trauma procedures, thereby minimizing radiation exposure among other benefits. May 15, 2020
Histogen Publishes Preclinical Data on Spinal Disc Repair
The company's cell conditioned media has been shown to stimulate stem cells in vivo, possibly leading to the repair of the intravertebral disc matrix. May 15, 2020
Back 2 Basics Gains FDA Clearance for eCarbon Spinal Rod
This is the first carbon composite spinal rod cleared for market as an adjunct in the treatment of spinal indications, other than oncological. May 14, 2020
